Duloxetine: Meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder (vol 6, pg 587, 2006)

被引：0
|
作者：
Acharya, Nayan
机构：
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2007年 / 27卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [31] Clinical consensus regarding the importance of rapid reduction in depressive symptoms in major depressive disorder with acute suicidal ideation or behavior (MDSI)
    Borentain, S.
    Nash, A.
    Daly, E.
    Joshi, K.
    O'Hara, M.
    Zhangi, Q.
    Mathews, M.
    Haughey, S.
    Richards, S.
    Anjo, J.
    Zante, D.
    Perry, R.
    EUROPEAN PSYCHIATRY, 2022, 65 : S558 - S558
  • [32] Prevalence, clinical correlates and IQ of suicidal ideation in drug naive Chinese Han patients with major depressive disorder
    Li, Xirong
    Liu, Haixia
    Hou, Ruihua
    Baldwin, David S.
    Li, Renjun
    Cui, Kaiyan
    Liu, Chuanxin
    Sun, Qian
    Wang, Gang
    Tan, Qingrong
    Xu, Xiufeng
    Zhao, Jingping
    Ning, Yuping
    Sun, Xueli
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 248 : 59 - 64
  • [33] Clinical Response of Major Depressive Disorder Patients With Suicidal Ideation to Individual Target-Transcranial Magnetic Stimulation
    Tang, Nailong
    Sun, Chuanzhu
    Wang, Yangtao
    Li, Xiang
    Liu, Junchang
    Chen, Yihuan
    Sun, Liang
    Rao, Yang
    Li, Sanzhong
    Qi, Shun
    Wang, Huaning
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [34] Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis (vol 5, pg 33, 2017)
    Nathan, S. D.
    Albera, C.
    Bradford, W. Z.
    LANCET RESPIRATORY MEDICINE, 2017, 5 (01): : E7 - E7
  • [35] Calcium channel blockers in hypertension: Reappraisal after new trials and major meta-analyses (vol 14, pg 1074, 2001)
    Opie, LH
    AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (12) : 1280 - 1280
  • [36] Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder
    Bech, Per
    Kajdasz, Daniel K.
    Porsdal, Vibeke
    PSYCHOPHARMACOLOGY, 2006, 188 (03) : 273 - 280
  • [37] Meta-analysis of cognitive function in vortioxetine clinical trials in major depressive disorder
    McIntyre, R.
    Harrison, J.
    Loft, H.
    Jacobson, W.
    Olsen, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S459 - S460
  • [38] Altered gray matter volumes and plasma IL-6 level in major depressive disorder patients with suicidal ideation
    Guo, Yingrui
    Jiang, Xiaowei
    Jia, Linna
    Zhu, Yue
    Han, Xinyu
    Wu, Yifan
    Liu, Wen
    Zhao, Wenhui
    Zhu, Huaqian
    Wang, Dahai
    Tu, Zhaoyuan
    Zhou, Yifang
    Sun, Qikun
    Kong, Lingtao
    Wu, Feng
    Tang, Yanqing
    NEUROIMAGE-CLINICAL, 2023, 38
  • [39] Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications
    Maund, Emma
    Tendal, Britta
    Hrobjartsson, Asbjorn
    Jorgensen, Karsten Juhl
    Lundh, Andreas
    Schroll, Jeppe
    Gotzsche, Peter C.
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [40] Clinical and economic burden of major depressive disorder with acute suicidal ideation or behavior in a US Veterans Health Affairs database
    Neslusan, Cheryl
    Chopra, Ishveen
    Joshi, Kruti
    Voelker, Jennifer
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (09) : 1603 - 1611
12345